U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Criminal Investigations
  4. Press Releases
  5. June 16, 2017: Leawood Woman Charged With Importing Misbranded Drugs
  1. Press Releases

June 16, 2017: Leawood Woman Charged With Importing Misbranded Drugs

 

 

 

OCI Small Clear Seal

 


 

 

 

Food and Drug Administration 
Office of Criminal Investigations

 


 
 

             U.S. Department of Justice Press Release

 

  

For Immediate Release
June 16, 2017

United States Department of Justice

District of Kansas

KANSAS CITY, KAN. - A Leawood woman was charged Friday with importing $194,000 worth of misbranded drugs, U.S. Attorney Tom Beall said. 

Kathleen Stegman, 59, who owned Midwest Medical Aesthetics Center, Inc., of Leawood, Kan., was charged with obtaining Botox, Dysport, Restylane, Perlane and Sculptra from foreign sources. The drugs did not meet Food and Drug Administration labeling requirements. The crime is alleged to have occurred in 2011, 2012 and 2013.

 

In October 2016, Stegman was sentenced to 51 months in federal prison for tax evasion.

 

If convicted, she faces up to three years in federal prison, a fine up to $250,000 and forfeiture. The Food and Drug Administration’s Office of Criminal Investigation investigated. Assistant U.S. Attorney Tanya Treadway is prosecuting.

 

Component(s): 

USAO - Kansas

 

 

 

 

Back to Top